Open access
Sep 2026
Diagnosis and treatment decision of an IDH-mutant glioma through CSF-based cfDNA sequencing
Abstract Classification of tumors of the central nervous system currently requires tumor tissue analysis for histology and molecular markers, according to the 2021 WHO Classification of Tumors of the Central Nervous System. Cerebrospinal fluid (CSF)-based cell-free DNA (cfDNA) sequencing detects these defining molecula...
E. Fouarge, Rouzbeh Banan, S. Schulz et al.
· Neuro-Oncology Advances · 0 citations